(Q47251856)

12 January 2018

title

Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers (English)

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

26 August 2023

0 references

0 references

Cerebral ventriculography

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

author name string

H. Nybäck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

B. M. Berggren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

T. Hindmarsh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

G. Sedvall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

F. A. Wiesel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6196802

26 August 2023

language of work or name

English

0 references

publication date

1 August 1983

1 reference

12 January 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0165178183900033?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

https://api.elsevier.com/content/article/PII:0165178183900033?httpAccept=text/plain

26 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

26 August 2023

1 reference

12 January 2018

volume

9

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

301-308

1 reference

12 January 2018

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Central dopamine turnover in schizophrenic syndromes.

26 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

CT scan variants and genetic heterogeneity in schizophrenia

26 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

26 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cognitive impairment associated with morphological brain abnormalities on computed tomography in chronic schizophrenic patients

26 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Differentiation of chronic schizophrenics with and without ventricular enlargement by the Luria-Nebraska Neuropsychological Battery

26 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Structural brain deficits in schizophrenia. Identification by computed tomographic scan density measurements

26 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Computer assisted tomography of intracranial CSF circulation using a water-soluble contrast medium

26 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Gross Pathology of the Cerebellum in Patients Diagnosed and Treated as Functional Psychiatric Disorders

26 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Evaluation of CT scans in tardive dyskinesia

26 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

The dementia of dementia praecox.

26 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

26 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

26 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

26 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Protein measurement with the Folin phenol reagent

26 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Computed tomography of the brain in patients with acute psychosis and in healthy volunteers.

26 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cortical and central atrophy in chronic schizophrenia. A controlled study.

26 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic Schizophrenics

26 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia

26 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cerebral ventricular size in twins discordant for schizophrenia

26 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Sulcal prominence in young chronic schizophrenic patients: CT scan findings associated with impairment on neuropsychological tests

26 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.

26 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients

26 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

26 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment

26 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Familial aspects of CT scan abnormalities in chronic schizophrenic patients

26 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Computed tomography in schizophreniform disorder and other acute psychiatric disorders

26 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

26 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Structural Abnormalities in the Cerebral Cortex of Chronic Schizophrenic Patients

26 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

Dopamine metabolites in human brain

26 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0165-1781(83)90003-3

26 August 2023

Identifiers

1 reference

12 January 2018

1 reference

12 January 2018